Long-term follow-up highlights the durability and efficacy of ACI
1st on the web (June 3, 2009)
Off-label use of a collagen membrane for ACI in United States shows decreased hypertrophy
1st on the web (June 2, 2009)
Chondroprotective strategy delivers antisense sequence to cells by virus
1st on the web (June 1, 2009)
Purified stem cell group shows greater levels of Type II collagen
1st on the web (May 29, 2009)
Mid-term follow-up shows continued improvement in patients treated with MACI
1st on the web (May 27, 2009)
Companies face different regulatory requirements in Europe, United States for cell therapies
1st on the web (May 26, 2009)
Follow-up of 10 to 20 years highlights the durability and efficacy of ACI in the knee
ORTHOPAEDICS TODAY EUROPE (September/October 2009)
Benefit of microfracture, implant for cartilage defects seen in early studies
ORTHOPAEDICS TODAY EUROPE (September/October 2009)
Good results seen at 17 years follow-up of more than 1,000 mosaicplasty cases
ORTHOPEDICS TODAY (July 2009)
Special concerns come into play when treating athletes with cartilage injuries
ORTHOPEDICS TODAY (November 2009)